Contact Person : Marilyn B. Turner; Last Date for the submission of abstract : 08-Feb-2019; The growth of the medical software industry outpaces the design of FDAs regulatory process. In some instances clinicians have weighed the risk of software failure against the benefits of using a device at all. Device software is often used in conjunction with other software-based devices, but their